To successfully deliver innovative and life-changing therapies, you need solutions that push what’s possible. That’s where we come in. No matter the extent of your needs, Svar Life Science can be your expert partner for analytical products and services that help accelerate your drug development.
We are committed to your success and strive for a long-term partnership. We hope to become your expert partner and continue to deliver competence and excellence in every future project.
Read more about the different solutions and services we provide to assist the development of new drugs and therapies – and find out how we can become your expert partner.
We offer a comprehensive portfolio of life science products supporting the development of new drugs and provide tools for patient diagnosis and monitoring within inflammatory diseases. Our portfolio consists of immunoassays as well as Mechanism-of-Action (MoA) based functional, cellular assays for use throughout the drug development process.
Our solutions are used in everything from commercial laboratories and life science research to clinical diagnostic markets.
We offer end-to-end bioanalytical support, answering your bioanalytical service needs, customer focused bioanalytical excellence. A flexible and experienced team adapting to your bioanalytical service needs.
Our role, as a bioanalytical service partner, is to facilitate your work and speed up your drug development process. Our GxP (GCP, GLP and GMP) compliant laboratory delivers bioanalytical collaborative excellence in every project!
We offer analyses using ligand-binding and cell-based assays focusing on large molecule bioanalysis and have years of experience with antibody and peptide-based drugs, new modalities, and gene and vector based-therapies.
Our custom development services are renowned for its reliability, with innovative solutions tailored to your assay development and manufacturing needs.
When commercial off-the-shelf products are not available, we can develop a solution that provides the quality results you need.
We offer a range of cell-based custom development services including an assay-ready cell service and master cell bank development. Our team of scientists will work with you to deliver a cell-based solution that provides the quality results you expect.
Our ISO Accredited and GLP Compliant Laboratories ensure that you can benefit from traceability of your study data and being in full compliance with regulatory requirements.
Our Laboratory Services have been accredited for more than 20 years. SWEDAC accredits us in accordance with the ISO15189:2012 standard, and as of 2023 Svar's QC laboratories have been inspected by an independent auditor (Swedish Medical Products Agency) and approved for QC analysis in line with the applicable GMP regulations for potency testing of biologics.
In addition, our Diagnostic Laboratory meets the requirements of EA-2/15, which means that the scope of accreditation is continuously adapted to internal requirements. For patient safety reasons, our policy is that even non-accredited analyses must comply with defined quality assurance routines.
Svar CRO Services also meets the GLP (Good Laboratory Practice) requirements set by the OECD. GLP is a quality assurance system that covers the organizational process and the relations that prevail when non-clinical safety studies on humans and the environment are planned, carried out, supervised, and reported. The principles of GLP are also used for documentation and accountability of method validation and sample analysis under Good Clinical Practice (GCP).
We help our customers with clinical testing, offering a comprehensive range of individual tests and test panels, many of which are available for urgent testing. In addition, we provide testing services and support for therapeutic drug monitoring.
By providing valuable diagnostic information and services based on innovative clinical solutions to assist in patient treatment decisions, Wieslab Diagnostic Services help clinicians reach the correct diagnosis fast.
Recently, we have added the SIMOA HD-X Analyzer™ to our laboratory, which allows us to expand our testing to new markers, including blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage in patients.
We are flexible, efficient, and can assist with anything from small sample studies to large projects with thousands of samples. So, regardless of your needs, we are here to support you in your research.
We have a wide range of assays available across multiple technological platforms. We are flexible, efficient, and can assist with anything from small sample studies to large projects with thousands of samples.
Assays for research projects that can be tested range from our diagnostic test portfolio - with neuro-immunology, nephrology, rheumatology, and gastroenterology testing – to a wide selection of biomarkers available on our MSD (electrochemiluminescence) or SIMOA ultra-sensitive digital immunoassay platforms.